My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
December 2011/January 2012
Global ID
Early HIV Treatment Study Named Breakthrough of the Year

The HIV Prevention Trials Network 052 (HPTN 052) study, led by Myron S. Cohen, MD, FIDSA, of the University of North Carolina (UNC) in Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science. HPTN 052 evaluated whether antiretroviral drugs can prevent sexual transmission of HIV among couples in which one partner has HIV and the other does not. The research found that early treatment with antiretroviral therapy reduced sexual transmission of HIV in these couples by at least 96 percent. Time magazine also highlighted HIV treatment as prevention as one of the top 10 medical breakthroughs of 2011.

Dr. Cohen is associate vice chancellor for global health and the J. Herbert Bate Distinguished Professor of Medicine, Microbiology, and Immunology at UNC; public health director for the UNC Institute of Global Health; and infectious disease chief in the Division of Clinical Infectious Diseases. A member of HIVMA and the Center for Global Health Policy’s Scientific Advisory Committee, Dr. Cohen has also served on the IDSA Annual Meeting Program Committee.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
Help Boost ID Participation in Physician Compensation Survey
Webinar: Billing and Coding Update for 2012
Congress Should Repeal Flawed Physician Payment Formula
IDSA Comments on Medicare Conditions of Participation
Global ID
Early HIV Treatment Study Named Breakthrough of the Year
PEPFAR Takes Hit, Military HIV Research Program Survives
Level of HIV in Blood Major Factor in Sexual Transmission
“Totally” Drug Resistant TB in India
Policy and Advocacy
FDA Limits Cephalosporin Use in Food Animals
IDSA, PIDS, SHEA Urge Mandatory HCW Influenza Vaccination
Organ Transplant Guidelines Should Take Balanced Approach
IDSA Raises Alarm on Anti-Infective Drug Shortages
ID Funding Should Be Federal Budget Priority
Your Colleagues
Check Out “My IDSA” for Latest Member News
Education & Resources
Antimicrobial Resistance CME Activity Available Online
Discount for IDSA Members on OUP Books
Top Stories
From the President: IDSA Needs You, More Than Ever
NIAID Seeks Lead Investigators for Antibacterial Resistance Clinical Research Network
EIN Update: Cases of M. abscessus Continue to Pose Treatment Challenges
IDSA Journal Club

 



IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.